As ABCG2 was demonstrated in multidrug-resistant cancer cell lines, the first identified protein substrates were chemotherapeutic agents such as mitoxantrone, flavopiridol, methotrexate, irinotecan, and its active metabolite SN-38. The gene discussed is ABCG2; the disease is cancer.